These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 7982368)

  • 21. Continuous and intermittent salbutamol tablet administration in asthmatic children.
    Lenney W; Milner AD; Hiller EJ
    Br J Dis Chest; 1979 Jul; 73(3):277-81. PubMed ID: 399859
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A placebo-controlled, crossover comparison of salmeterol and salbutamol in patients with asthma.
    Leblanc P; Knight A; Kreisman H; Borkhoff CM; Johnston PR
    Am J Respir Crit Care Med; 1996 Aug; 154(2 Pt 1):324-8. PubMed ID: 8756801
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An evaluation of a controlled-release aminophylline tablet (Phyllocontin Continus) as a concomitant therapy in patients receiving salbutamol.
    Boyd G; Clark CJ
    J Int Med Res; 1979; 7 Suppl 1():34-5. PubMed ID: 374162
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cross tolerance to salbutamol occurs independently of beta2 adrenoceptor genotype-16 in asthmatic patients receiving regular formoterol or salmeterol.
    Lee DK; Jackson CM; Bates CE; Lipworth BJ
    Thorax; 2004 Aug; 59(8):662-7. PubMed ID: 15282385
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of intravenous salbutamol (albuterol) and aminophylline in the treatment of acute asthmatic attacks.
    Greif J; Markovitz L; Topilsky M
    Ann Allergy; 1985 Sep; 55(3):504-6. PubMed ID: 3898925
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Delayed-release salbutamol, a new beta-mimetic with prolonged action. Results of a comparative study against theophylline L.A].
    Brune J; Desfougères JL
    Allerg Immunol (Paris); 1991 Oct; 23(8):358-64. PubMed ID: 1777051
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combination of salbutamol inhalational powder and tablets in asthma.
    Grimwood K; Fergusson DM; Dawson KP
    Arch Dis Child; 1983 Apr; 58(4):283-5. PubMed ID: 6342544
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Continuous versus intermittent nebulization of salbutamol in acute severe asthma: a randomized, controlled trial.
    Besbes-Ouanes L; Nouira S; Elatrous S; Knani J; Boussarsar M; Abroug F
    Ann Emerg Med; 2000 Sep; 36(3):198-203. PubMed ID: 10969220
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The efficacy, as modified by the circadian rhythm of salbutamol administered by different routes.
    Lahdensuo A; Alanko K
    Scand J Respir Dis; 1976; 57(5):231-8. PubMed ID: 792993
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The therapeutic effects of inhaled long-acting beta2-adrenergics (LABA) and corticosteroids (ICS) are not affected by their inhalation sequence in moderate/persistent asthma.
    Dal Negro RW; Micheletto C; Tognella S; Trevisan F; Guerriero M
    Eur Ann Allergy Clin Immunol; 2006 May; 38(5):153-7. PubMed ID: 17058847
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic regimes for acute bronchial asthma.
    Anantharaman V
    Singapore Med J; 1993 Dec; 34(6):534-7. PubMed ID: 8153718
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A twelve month comparison of salmeterol with salbutamol in asthmatic patients. European Study Group.
    Britton MG; Earnshaw JS; Palmer JB
    Eur Respir J; 1992 Oct; 5(9):1062-7. PubMed ID: 1426215
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Changes in the heart rhythm and slow-release beta-2 agonist therapy (peroral) in asthmatic patients. A Holter study].
    Malerba M; Politi A; Filippi B; Zambruni U; Grassi V
    Recenti Prog Med; 1992 Dec; 83(12):665-71. PubMed ID: 1494703
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of nebulized ipratropium bromide with salbutamol vs salbutamol alone in acute asthma exacerbation in children.
    Watanasomsiri A; Phipatanakul W
    Ann Allergy Asthma Immunol; 2006 May; 96(5):701-6. PubMed ID: 16729783
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comparative crossover study of two long-acting bronchodilator preparations.
    Maneksha S
    Curr Med Res Opin; 1976; 4(3):207-11. PubMed ID: 780061
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Controlled release salbutamol tablets versus aminophylline in the control of reversible airways obstruction.
    Higenbottam TW; Khan MA; Williams DO; Mikhail JR; Peake MD; Hughes J
    J Int Med Res; 1989; 17(5):435-41. PubMed ID: 2680678
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy, tolerability, and effect on asthma-related quality of life of formoterol bid via multidose dry powder inhaler and albuterol QID via metered dose inhaler in patients with persistent asthma: a multicenter, randomized, double-blind, double-dummy, placebo-controlled, parallel-group study.
    Busse W; Levine B; Andriano K; Lavecchia C; Yegen U
    Clin Ther; 2004 Oct; 26(10):1587-98. PubMed ID: 15598475
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapeutic equivalence between bambuterol, 10 mg once daily, and terbutaline controlled release, 5 mg twice daily, in mild to moderate asthma.
    Fugleholm AM; Ibsen TB; Laxmyr L; Svendsen UG
    Eur Respir J; 1993 Nov; 6(10):1474-8. PubMed ID: 8112441
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of the clinical efficacy of salmeterol and sustained-release tulobuterol (patch) on inadequately controlled asthma patients on inhaled corticosteroids.
    Fujimoto K; Komatsu Y; Yasuo M; Urushihata K; Kubo K
    J Asthma; 2006 Sep; 43(7):501-7. PubMed ID: 16939989
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhaled salmeterol and salbutamol in asthmatic patients. An evaluation of asthma symptoms and the possible development of tachyphylaxis.
    Ullman A; Hedner J; Svedmyr N
    Am Rev Respir Dis; 1990 Sep; 142(3):571-5. PubMed ID: 1975162
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.